BECN1 and colorectal carcinoma: Overall, our meta-analysis pooled the outcomes of 2297 patients with CRC from 9 individual studies and found that the expression of Beclin-1 was not associated with OS (HR = 0.68, 95% CI 0.31–0.52, P > 0.05).